TABLE OF CONTENTS
|  |  |  | Volume 34, Issue 42 (October 2015) |  | In this issue Review Original Articles Corrigendum
Also new    AOP | |  |  |  | Advertisement |  | |  |  | Review | Top |  | The origin of breast tumor heterogeneityA Skibinski and C Kuperwasser Oncogene 2015 34: 5309-5316; advance online publication, February 23, 2015; 10.1038/onc.2014.475 Abstract | Full Text |  | Original Articles | Top |  | Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer OPENR K Bikkavilli, S Avasarala, M Van Scoyk, J Arcaroli, C Brzezinski, W Zhang, M G Edwards, M K K Rathinam, T Zhou, J Tauler, S Borowicz, Y A Lussier, B A Parr, C D Cool and R A Winn Oncogene 2015 34: 5317-5328; advance online publication, March 2, 2015; 10.1038/onc.2015.2 Abstract | Full Text |  |  |  | Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagyL R Gomes, A T Vessoni and C F M Menck Oncogene 2015 34: 5329-5340; advance online publication, January 26, 2015; 10.1038/onc.2014.461 Abstract | Full Text |  |  |  | Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia OPEND Kern, G Regl, S W Hofbauer, P Altenhofer, G Achatz, A Dlugosz, H Schnidar, R Greil, T N Hartmann and F Aberger Oncogene 2015 34: 5341-5351; advance online publication, February 2, 2015; 10.1038/onc.2014.450 Abstract | Full Text |  |  |  | Beclin 1 regulates growth factor receptor signaling in breast cancerR A Rohatgi, J Janusis, D Leonard, K D Bellvé, K E Fogarty, E H Baehrecke, S Corvera and L M Shaw Oncogene 2015 34: 5352-5362; advance online publication, February 2, 2015; 10.1038/onc.2014.454 Abstract | Full Text |  |  |  | IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagyH Dong, L Tian, R Li, C Pei, Y Fu, X Dong, F Xia, C Wang, W Li, X Guo, C Gu, B Li, A Liu, H Ren, C Wang and H Xu Oncogene 2015 34: 5363-5371; advance online publication, January 26, 2015; 10.1038/onc.2014.459 Abstract | Full Text |  |  |  | Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factorY-H Cui, Y Suh, H-J Lee, K-C Yoo, N Uddin, Y-J Jeong, J-S Lee, S-G Hwang, S-Y Nam, M-J Kim and S-J Lee Oncogene 2015 34: 5372-5382; advance online publication, February 2, 2015; 10.1038/onc.2014.466 Abstract | Full Text |  |  |  | CACNA2D2 promotes tumorigenesis by stimulating cell proliferation and angiogenesisM Warnier, M Roudbaraki, S Derouiche, P Delcourt, A Bokhobza, N Prevarskaya and P Mariot Oncogene 2015 34: 5383-5394; advance online publication, January 26, 2015; 10.1038/onc.2014.467 Abstract | Full Text |  |  |  | Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression OPENE T Goka and M E Lippman Oncogene 2015 34: 5395-5405; advance online publication, February 9, 2015; 10.1038/onc.2014.468 Abstract | Full Text |  | Corrigendum | Top |  | Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancerR K Bikkavilli, S Avasarala, M Van Scoyk, J Arcaroli, C Brzezinski, W Zhang, M G Edwards, M K K Rathinam, T Zhou, J Tauler, S Borowicz, Y A Lussier, B A Parr, C D Cool and R A Winn Oncogene 2015 34: 5406; 10.1038/onc.2015.165 Full Text |  |  |  | Epidermal growth factor (EGF) activates nuclear factor-κB through IκBα kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IκBαG Sethi, K S Ahn, M M Chaturvedi and B B Aggarwal Oncogene 2015 34: 5407; 10.1038/onc.2015.313 Full Text |  |  |  | Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrinS Kale, R Raja, D Thorat, G Soundararajan, T V Patil and G C Kundu Oncogene 2015 34: 5408-5410; 10.1038/onc.2015.315 Full Text |  |  |  |  | Advertisement |  | Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952.
Explore the benefits of submitting your next research article: http://bit.ly/1vUuaXe |  | | |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment